Alignment Healthcare, Inc. ALHC
812 filings, 5 in the last 30 days
SEC filing indexWhat the 8-Ks said
None of the officer, auditor, restatement, cyber, restructuring, listing, impairment or debt 8-Ks in the last 3 years
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 95 events
- Nov 9, 2026 Planned sale Joseph Konowiecki (Chairman / EVP, Corporate Affairs) gave notice of a planned sale of 5,500 shares worth about $40KForm 144, approximate sale date Nov 10, 2026
- Oct 29, 2026 8-K Quarterly results8-K item 2.02
- Oct 29, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Oct 8, 2026 8-K Regulation FD disclosure8-K item 7.01
- Oct 5, 2026 Planned sale Hyong (Ken) Kim, M.D. (Chief Medical Officer) gave notice of a planned sale of 36,000 shares worth about $305KForm 144, approximate sale date Oct 6, 2026
- Sep 16, 2026 Planned sale Joseph Konowiecki (Director / EVP, Corporate Affairs) gave notice of a planned sale of 26,000 shares worth about $226KForm 144, approximate sale date Sep 17, 2026
- Sep 10, 2026 Planned sale JEK TRUST U/A DTD 02/08/2021 (Director, Officer) gave notice of a planned sale of 500,000 shares worth about $6.5MForm 144, approximate sale date Sep 10, 2026, under a 10b5-1 plan adopted May 27, 2026
- Sep 9, 2026 Planned sale John Kao (Chief Executive Officer / Director) gave notice of a planned sale of 405,000 shares worth about $5.3MForm 144, approximate sale date Sep 10, 2026
- Sep 9, 2026 Planned sale Dawn C. Maroney (President) gave notice of a planned sale of 130,000 shares worth about $1.7MForm 144, approximate sale date Sep 10, 2026
- Aug 14, 2026 Planned sale DAWN MARONEY (Officer) gave notice of a planned sale of 5,000 shares worth about $67KForm 144, approximate sale date Aug 14, 2026, under a 10b5-1 plan adopted Mar 13, 2026
- Jul 30, 2026 Planned sale John Kao (Chairman and Chief Executive Officer(2)) adopted a 10b5-1 trading planreported in the 10-Q, up to 800,000 shares, runs to Feb 26, 2027
- Jul 30, 2026 8-K Quarterly results8-K item 2.02
- Jul 30, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Jul 15, 2026 Planned sale DAWN MARONEY (Officer) gave notice of a planned sale of 177,068 shares worth about $3.8MForm 144, approximate sale date Jul 15, 2026, under a 10b5-1 plan adopted Mar 13, 2026
- Jul 10, 2026 Planned sale JEK TRUST U/A DTD 02/08/2021 (Director, Officer) gave notice of a planned sale of 596,000 shares worth about $12.5MForm 144, approximate sale date Jul 10, 2026, under a 10b5-1 plan adopted Nov 21, 2025
- Jul 1, 2026 Planned sale Joseph Konowiecki (Director) gave notice of a planned sale of 25,000 shares worth about $600KForm 144, approximate sale date Jul 1, 2026
- Jun 26, 2026 Planned sale Joseph Konowiecki (Director) gave notice of a planned sale of 25,000 shares worth about $575KForm 144, approximate sale date Jun 26, 2026, under a 10b5-1 plan adopted Mar 4, 2026
- Jun 18, 2026 Planned sale Joseph Konowiecki (Director) gave notice of a planned sale of 25,000 shares worth about $550KForm 144, approximate sale date Jun 18, 2026, under a 10b5-1 plan adopted Mar 4, 2026
- Jun 12, 2026 Planned sale SEBASTIAN BURZACCHI (Officer) gave notice of a planned sale of 1,142 shares worth about $23KForm 144, approximate sale date Jun 12, 2026, under a 10b5-1 plan adopted Mar 13, 2026
- Jun 12, 2026 Planned sale HYONG J KIM (Officer) gave notice of a planned sale of 35,951 shares worth about $728KForm 144, approximate sale date Jun 12, 2026, under a 10b5-1 plan adopted Mar 13, 2026
- Jun 11, 2026 Planned sale Joseph Konowiecki (Director) gave notice of a planned sale of 25,000 shares worth about $525KForm 144, approximate sale date Jun 11, 2026, under a 10b5-1 plan adopted Mar 4, 2026
- Jun 9, 2026 8-K Shareholder vote results8-K item 5.07
- Jun 2, 2026 Buy Kent Mark D. (President - MSO) bought $198Kopen-market purchase on Jun 2, 2026
- May 12, 2026 8-K Bylaws or fiscal year changed, Regulation FD disclosure8-K items 5.03, 7.01
- May 11, 2026 Planned sale JEK TRUST U/A DTD 02/08/2021 (Director, Officer) gave notice of a planned sale of 596,000 shares worth about $10.7MForm 144, approximate sale date May 11, 2026, under a 10b5-1 plan adopted Nov 21, 2025
- Apr 30, 2026 Planned sale Joseph Konowiecki (Chairman of the Board) adopted a 10b5-1 trading planreported in the 10-Q, up to 100,000 shares, runs to Jun 3, 2027
- Apr 30, 2026 Planned sale Dawn Maroney (President) adopted a 10b5-1 trading planreported in the 10-Q, up to 942,729 shares, runs to Jun 30, 2027
- Apr 30, 2026 Planned sale Hyong (Ken) Kim, M.D. (Chief Medical Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 139,389 shares, runs to Mar 5, 2027
- Apr 30, 2026 Planned sale Sebastian Burzacchi (Chief Operating Officer - MSO) adopted a 10b5-1 trading planreported in the 10-Q, up to 32,920 shares, runs to Mar 31, 2027
- Apr 30, 2026 8-K Quarterly results8-K item 2.02
- Apr 30, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Apr 15, 2026 Planned sale DAWN MARONEY (Officer) gave notice of a planned sale of 90,000 shares worth about $1.9MForm 144, approximate sale date Apr 15, 2026, under a 10b5-1 plan adopted May 22, 2025
- Apr 7, 2026 Planned sale JEK TRUST U/A DTD 02/08/2021 (Director, Officer) gave notice of a planned sale of 548,000 shares worth about $10.2MForm 144, approximate sale date Apr 7, 2026, under a 10b5-1 plan adopted Nov 21, 2025
- Apr 6, 2026 Planned sale James M. Head (Chief Financial Officer) gave notice of a planned sale of 12,000 shares worth about $224KForm 144, approximate sale date Apr 7, 2026
- Apr 1, 2026 Planned sale Christopher Joyce (Officer) gave notice of a planned sale of 18,013 shares worth about $317KForm 144, approximate sale date Apr 1, 2026, under a 10b5-1 plan adopted Sep 8, 2025
- Mar 23, 2026 Planned sale JEK TRUST U/A DTD 02/08/2021 (Director, Officer) gave notice of a planned sale of 118,000 shares worth about $2.0MForm 144, approximate sale date Mar 23, 2026, under a 10b5-1 plan adopted Nov 21, 2025
- Mar 19, 2026 Planned sale ANDREAS WAGNER (Officer) gave notice of a planned sale of 11,602 shares worth about $211KForm 144, approximate sale date Mar 19, 2026, under a 10b5-1 plan adopted Nov 21, 2025
- Mar 16, 2026 Planned sale Robert L. Scavo (Chief Information Officer) gave notice of a planned sale of 12,145 shares worth about $206KForm 144, approximate sale date Mar 18, 2026
- Mar 16, 2026 Planned sale Andreas P. Wagner (Chief Human Resources Officer) gave notice of a planned sale of 13,271 shares worth about $225KForm 144, approximate sale date Mar 18, 2026
- Mar 16, 2026 Planned sale John Kao (Chief Executive Officer) gave notice of a planned sale of 80,788 shares worth about $1.4MForm 144, approximate sale date Mar 18, 2026
- Mar 16, 2026 Planned sale Dawn C. Maroney (President) gave notice of a planned sale of 40,643 shares worth about $691KForm 144, approximate sale date Mar 18, 2026
- Mar 16, 2026 Planned sale Christopher Joyce (Chief Legal & Administrative Officer) gave notice of a planned sale of 27,592 shares worth about $469KForm 144, approximate sale date Mar 18, 2026
- Mar 16, 2026 Planned sale Sebastian Burzacchi (Chief Operating Officer - MSO) gave notice of a planned sale of 16,987 shares worth about $289KForm 144, approximate sale date Mar 18, 2026
- Mar 16, 2026 Planned sale Hyong (Ken) Kim, M.D. (Chief Medical Officer) gave notice of a planned sale of 38,762 shares worth about $659KForm 144, approximate sale date Mar 18, 2026
- Mar 10, 2026 Planned sale JEK TRUST U/A DTD 02/08/2021 (Director, Officer) gave notice of a planned sale of 180,000 shares worth about $3.3MForm 144, approximate sale date Mar 10, 2026, under a 10b5-1 plan adopted Mar 12, 2025
- Mar 10, 2026 Planned sale John Kao (Chief Executive Officer) gave notice of a planned sale of 50,000 shares worth about $922KForm 144, approximate sale date Mar 11, 2026
- Mar 10, 2026 Planned sale Dawn Maroney (President) gave notice of a planned sale of 30,000 shares worth about $553KForm 144, approximate sale date Mar 11, 2026
- Mar 10, 2026 Planned sale Robert L. Scavo (Chief Information Officer) gave notice of a planned sale of 4,100 shares worth about $76KForm 144, approximate sale date Mar 11, 2026
- Mar 4, 2026 Planned sale ANDREAS WAGNER (Officer) gave notice of a planned sale of 21,118 shares worth about $390KForm 144, approximate sale date Mar 4, 2026, under a 10b5-1 plan adopted Nov 21, 2025
- Mar 4, 2026 8-K Material agreement signed8-K item 1.01
- Mar 2, 2026 Offering Shelf registration: shares and other securities, amount not fixedS-3ASR · may offer, from time to time and in one or more offerings, shares of our common stock.
- Feb 27, 2026 Planned sale Andreas Wagner (Chief Human Resources Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 66,958 shares, runs to Nov 20, 2026
- Feb 27, 2026 Planned sale John Kao (Chief Executive Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 1,858,000 shares, runs to Aug 21, 2026
- Feb 27, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Feb 26, 2026 8-K Quarterly results8-K item 2.02
- Feb 9, 2026 Planned sale Andreas Wagner (Chief Human Resources Officer) gave notice of a planned sale of 22,500 shares worth about $489KForm 144, approximate sale date Feb 10, 2026
- Jan 12, 2026 8-K Regulation FD disclosure8-K item 7.01
- Jan 6, 2026 Planned sale HYONG J KIM (Officer) gave notice of a planned sale of 16,506 shares worth about $347KForm 144, approximate sale date Jan 6, 2026, under a 10b5-1 plan adopted Mar 14, 2025
- Jan 6, 2026 Planned sale DAWN MARONEY (Officer) gave notice of a planned sale of 318,152 shares worth about $6.7MForm 144, approximate sale date Jan 6, 2026, under a 10b5-1 plan adopted May 22, 2025
- Dec 23, 2025 Planned sale Hyong (Ken) Kim, M.D. (Chief Medical Officer) gave notice of a planned sale of 13,000 shares worth about $262KForm 144, approximate sale date Dec 24, 2025
- Dec 23, 2025 Planned sale John Kao (Chief Executive Officer) gave notice of a planned sale of 600,000 shares worth about $12.1MForm 144, approximate sale date Dec 24, 2025
- Dec 23, 2025 Planned sale Dawn Maroney (President) gave notice of a planned sale of 275,000 shares worth about $5.6MForm 144, approximate sale date Dec 24, 2025
- Dec 23, 2025 Planned sale Christopher Joyce (Chief Legal & Admin. Officer) gave notice of a planned sale of 15,000 shares worth about $303KForm 144, approximate sale date Dec 24, 2025
- Dec 23, 2025 Planned sale Robert Scavo (Chief Information Officer) gave notice of a planned sale of 68,000 shares worth about $1.4MForm 144, approximate sale date Dec 24, 2025
- Dec 15, 2025 Planned sale DAWN MARONEY (Officer) gave notice of a planned sale of 213,319 shares worth about $4.1MForm 144, approximate sale date Dec 15, 2025, under a 10b5-1 plan adopted May 22, 2025
- Dec 12, 2025 Planned sale DAWN MARONEY (Officer) gave notice of a planned sale of 16,681 shares worth about $324KForm 144, approximate sale date Dec 12, 2025, under a 10b5-1 plan adopted May 22, 2025
- Dec 11, 2025 Planned sale Sebastian Burzacchi (Chief Operating Officer - MSO) gave notice of a planned sale of 12,585 shares worth about $242KForm 144, approximate sale date Dec 10, 2025
- Dec 10, 2025 Planned sale JEK TRUST U/A DTD 02/08/2021 (Director, Officer) gave notice of a planned sale of 540,000 shares worth about $10.4MForm 144, approximate sale date Dec 10, 2025, under a 10b5-1 plan adopted Mar 12, 2025
- Dec 10, 2025 Planned sale General Atlantic (ALN HLTH), L.P. (Affiliate) gave notice of a planned sale of 11,119,494 shares worth about $206.5MForm 144, approximate sale date Dec 10, 2025
- Dec 8, 2025 Planned sale CHRISTOPHER J. JOYCE (Officer) gave notice of a planned sale of 30,317 shares worth about $593KForm 144, approximate sale date Dec 8, 2025, under a 10b5-1 plan adopted Sep 8, 2025
- Nov 25, 2025 Planned sale Joseph Konowiecki (Director) gave notice of a planned sale of 25,000 shares worth about $475KForm 144, approximate sale date Nov 25, 2025
- Oct 30, 2025 Planned sale Christopher Joyce (Chief Legal & Administrative Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 95,455 shares, runs to Sep 11, 2026
- Oct 30, 2025 8-K Quarterly results8-K item 2.02
- Oct 30, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Sep 9, 2025 8-K Regulation FD disclosure8-K item 7.01
- Jul 30, 2025 Planned sale Dawn Maroney (President) adopted a 10b5-1 trading planreported in the 10-Q, up to 410,000 shares, runs to Jun 30, 2026
- Jul 30, 2025 8-K Quarterly results8-K item 2.02
- Jul 30, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- Jun 11, 2025 8-K Shareholder vote results8-K item 5.07
- May 1, 2025 Planned sale Hyong (Ken) Kim, M.D. (Chief Medical Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 172,034 shares, runs to Mar 13, 2026
- May 1, 2025 Planned sale Robert Scavo (Chief Information Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 108,097 shares, runs to Mar 21, 2026
- May 1, 2025 Planned sale Andreas Wagner (Chief Human Resources Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 39,063 shares, runs to Feb 27, 2026
- May 1, 2025 Planned sale John Kao (Chief Executive Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 1,710,000 shares, runs to Mar 20, 2026
- May 1, 2025 Planned sale Thomas Freeman (Chief Financial Officer) ended a 10b5-1 trading planreported in the 10-Q
- May 1, 2025 8-K Quarterly results8-K item 2.02
- May 1, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- Apr 15, 2025 8-K Director or officer change8-K item 5.02
- Apr 11, 2025 8-K Other events8-K item 8.01
- Feb 27, 2025 Planned sale Thomas Freeman (Chief Financial Officer) ended a 10b5-1 trading planreported in the 10-K, up to 518,000 shares, runs to Nov 28, 2025
- Feb 27, 2025 Planned sale Dawn Maroney (President) adopted a 10b5-1 trading planreported in the 10-K, up to 350,000 shares, runs to Aug 22, 2025
- Feb 27, 2025 Planned sale Christopher Joyce (Chief Legal & Administrative Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 50,678 shares, runs to Nov 14, 2025
- Feb 27, 2025 8-K Quarterly results8-K item 2.02
- Feb 27, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Jan 13, 2025 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
- Nov 25, 2024 8-K Material agreement signed, Material agreement ended, New debt or obligation, Unregistered share sale8-K items 1.01, 1.02, 2.03, 3.02
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 12, 2026 | 4 | Insider trade |
| Nov 9, 2026 | 144 | Notice of planned insider sale |
| Nov 5, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Oct 29, 2026 | 10-Q | Quarterly report |
| Oct 29, 2026 | 8-K | Quarterly results |
| Oct 8, 2026 | 8-K | Regulation FD disclosure |
| Oct 7, 2026 | 4 | Insider trade |
| Oct 5, 2026 | 144 | Notice of planned insider sale |
| Sep 18, 2026 | 4 | Insider trade |
| Sep 16, 2026 | 4 | Insider trade |
| Sep 16, 2026 | 144 | Notice of planned insider sale |
| Sep 11, 2026 | 4 | Insider trade |
| Sep 11, 2026 | 4 | Insider trade |
| Sep 10, 2026 | 144 | Notice of planned insider sale |
| Sep 9, 2026 | 144 | Notice of planned insider sale |
| Sep 9, 2026 | 144 | Notice of planned insider sale |
| Aug 18, 2026 | 4 | Insider trade |
| Aug 14, 2026 | 144 | Notice of planned insider sale |
| Aug 10, 2026 | 4 | Insider trade |
| Jul 31, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Jul 30, 2026 | 10-Q | Quarterly report |
| Jul 30, 2026 | 8-K | Quarterly results |
| Jul 16, 2026 | 4 | Insider trade |
| Jul 15, 2026 | 144 | Notice of planned insider sale |
| Jul 14, 2026 | 4 | Insider trade |
| Jul 10, 2026 | 144 | Notice of planned insider sale |
| Jul 2, 2026 | 4 | Insider trade |
| Jul 1, 2026 | 4 | Insider trade |
| Jul 1, 2026 | 144 | Notice of planned insider sale |
| Jun 26, 2026 | 4 | Insider trade |
| Jun 26, 2026 | 144 | Notice of planned insider sale |
| Jun 18, 2026 | 4 | Insider trade |
| Jun 18, 2026 | 144 | Notice of planned insider sale |
| Jun 15, 2026 | 4 | Insider trade |
| Jun 15, 2026 | 4 | Insider trade |
| Jun 12, 2026 | 144 | Notice of planned insider sale |
| Jun 12, 2026 | 144 | Notice of planned insider sale |
| Jun 12, 2026 | 4 | Insider trade |
| Jun 12, 2026 | 4 | Insider trade |
| Jun 11, 2026 | 144 | Notice of planned insider sale |
| Jun 9, 2026 | 8-K | Shareholder vote results |
| Jun 9, 2026 | 4 | Insider trade |
| Jun 9, 2026 | 4 | Insider trade |
| Jun 2, 2026 | 4 | Insider trade |
| Jun 2, 2026 | 3 | New insider |
| May 20, 2026 | 3 | New insider |
| May 19, 2026 | 4 | Insider trade |
| May 15, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| May 15, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| May 13, 2026 | 4 | Insider trade |
| May 12, 2026 | DEFA14A | Extra proxy material |
| May 12, 2026 | 8-K | Bylaws or fiscal year changed, Regulation FD disclosure |
| May 11, 2026 | 144 | Notice of planned insider sale |
| Apr 30, 2026 | 10-Q | Quarterly report |
| Apr 30, 2026 | 8-K | Quarterly results |
| Apr 24, 2026 | ARS | Annual report to shareholders |
| Apr 24, 2026 | DEFA14A | Extra proxy material |
| Apr 24, 2026 | DEF 14A | Proxy statement |
| Apr 15, 2026 | 144 | Notice of planned insider sale |
| Apr 15, 2026 | 4 | Insider trade |
| Apr 13, 2026 | 4 | Insider trade |
| Apr 8, 2026 | 4 | Insider trade |
| Apr 8, 2026 | 4 | Insider trade |
| Apr 7, 2026 | 144 | Notice of planned insider sale |
| Apr 6, 2026 | 144 | Notice of planned insider sale |
| Apr 1, 2026 | 144 | Notice of planned insider sale |
| Apr 1, 2026 | 4 | Insider trade |
| Mar 26, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Mar 23, 2026 | 144 | Notice of planned insider sale |
| Mar 23, 2026 | 4 | Insider trade |
| Mar 19, 2026 | 144 | Notice of planned insider sale |
| Mar 19, 2026 | 4 | Insider trade |
| Mar 19, 2026 | 4 | Insider trade |
| Mar 19, 2026 | 4 | Insider trade |
| Mar 19, 2026 | 4 | Insider trade |
| Mar 19, 2026 | 4 | Insider trade |
| Mar 19, 2026 | 4 | Insider trade |
| Mar 19, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 17, 2026 | 4 | Insider trade |
| Mar 16, 2026 | 144 | Notice of planned insider sale |
| Mar 16, 2026 | 144 | Notice of planned insider sale |
| Mar 16, 2026 | 144 | Notice of planned insider sale |
| Mar 16, 2026 | 144 | Notice of planned insider sale |
| Mar 16, 2026 | 144 | Notice of planned insider sale |
| Mar 16, 2026 | 144 | Notice of planned insider sale |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ALHC/export.csv") into a cell.